Articles published in Journal of Clinical Research & Bioethics have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Research & Bioethics has got h-index 19, which means every article in Journal of Clinical Research & Bioethics has got 19 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical Research & Bioethics.

  2022 2021 2020 2019 2018

Year wise published articles

60 61 52 9 16

Year wise citations received

155 184 182 171 162
Journal total citations count 1603
Journal Impact Factor 1.91
Journal 5 years Impact Factor 2.41
Journal CiteScore 5.23
Journal h-index 19
Important citations

Crepelle A (2016) A Market for Human Organs: An Ethical Solution to the Organ Shortage. Ind. Health L. Rev.13: 17.

Canca C (2016) The unjustified policy against a market in kidneys. Asian Bioethics Review 8: 177-194.

Gordon EJ, Patel CH, Sohn MW, Hippen B, Sherman LA (2015) Does financial compensation for living kidney donation change willingness to donate?. American Journal of Transplantation 15: 265-273.

ŽUNJIĆ S. Filozofijom.

Pavlovic D. CV/Doctora students/List of publications.

richiamo della Foresta I. Navigazione principale. Romania. 2015 May 5.

FEDI B, MANZONI A, PENCO S, POCAR V, TERRILE M. CONTRO LA VIVISEZIONE E LA SPERIMENTAZIONE ANIMALE.

Koonrungsesomboon N, Laothavorn J, Karbwang J (2016) Ethical considerations and challenges in first-in-human research. Translational Research 177: 6-18.

Habets MG. Ethical challenges in translational pluripotent stem cell research: Justifying leaps of faith (Doctoral dissertation, Utrecht University).

Satalkar P, Elger BS, Shaw DM (2016) Stakeholder views on participant selection for first-in-human trials in cancer nanomedicine. Current Oncology 23: e530.

Habets MG, van Delden JJ, Bredenoord AL (2016) The unique status of first-in-human studies: strengthening the social value requirement. Drug Discovery Today.

Blog OF. Supporting data from experts.

Chapman AR (2012) Improving Subject Safety in High-Risk Phase I Trials With Stem Cell-Based Candidate Therapies. AJOB Neuroscience 3: 18-20.

Helmchen H (2013) Ethische Grundvoraussetzungen klinischer Forschung. InEthik psychiatrischer Forschung. Springer Berlin Heidelberg pp. 39-56.

Napier S (2013) Challenging research on human subjects: justice and uncompensated harms. Theoretical medicine and bioethics 34: 29-51.

Smith SE, Reeder SJ (2013) What nurse practitioners should know about gene therapy. The Nurse Practitioner 38: 16-22.

Satalkar P, Elger BS, Shaw D (2016) Naming it ‘nano’: Expert views on ‘nano’terminology in informed consent forms of first-in-human nanomedicine trials. Nanomedicine : 933-940.

Greek R (2014) The Ethical Implications for Humans in Light of the Poor Predictive Value of Animal Models. International Journal of Clinical Medicine.

Genske A, Engel-Glatter S (2016) Rethinking risk assessment for emerging technology first-in-human trials. Medicine, Health Care and Philosophy 19: 125-139.

Jones RC, Greek R (2014) A review of the Institute of Medicine’s analysis of using chimpanzees in biomedical research. Science and engineering ethics 20: 481-504.